knowledge -WSS

knowledge

author：Wikipedia 2025-09-03 14:39:11 - browse：38791

Adam's take main illustration — Molly Ferguson/STAT

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： ALS treatment from Biogen, Ionis fails in study

knowledge

WSS

Why an extreme heat and wildfire smoke combination can be so dangerous

Our daughter's deadly disease: trisomy 18. We wanted to protect her

7 of the most gruesome medical devices in history

Abbott's new stent may help patients with peripheral artery disease

Caitlin Bernard's story shows physicians can't shy from advocacy

Hottest summer in 2,000 years puts focus on extreme heat, health

focus

knowledge

focus

Duchenne breakthrough therapy leaves behind pioneering families

WuXi Biologics beefs up its lobbying operation

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Guidelines to prevent youth baseball injuries need more muscle

The White House hikes tariffs on plastic syringes made in China

Alkermes shareholders re

Cherokee Nation medical school graduates its first class

Apple is now the first public company to be valued at $3 trillion

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

explore

Lilly’s weekly insulin works as well as daily products, new studies show

White House launches permanent pandemic office

Galapagos to make CAR

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Body of missing toddler recovered in Delaware River days after flood: Police

White House launches permanent pandemic office

knowledge

entertainment

knowledge

hotspot